Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli

Microb Cell Fact. 2017 Apr 24;16(1):68. doi: 10.1186/s12934-017-0681-1.


Background: The exploitation of the CRISPR/Cas9 machinery coupled to lambda (λ) recombinase-mediated homologous recombination (recombineering) is becoming the method of choice for genome editing in E. coli. First proposed by Jiang and co-workers, the strategy has been subsequently fine-tuned by several authors who demonstrated, by using few selected loci, that the efficiency of mutagenesis (number of mutant colonies over total number of colonies analyzed) can be extremely high (up to 100%). However, from published data it is difficult to appreciate the robustness of the technology, defined as the number of successfully mutated loci over the total number of targeted loci. This information is particularly relevant in high-throughput genome editing, where repetition of experiments to rescue missing mutants would be impractical. This work describes a "brute force" validation activity, which culminated in the definition of a robust, simple and rapid protocol for single or multiple gene deletions.

Results: We first set up our own version of the CRISPR/Cas9 protocol and then we evaluated the mutagenesis efficiency by changing different parameters including sequence of guide RNAs, length and concentration of donor DNAs, and use of single stranded and double stranded donor DNAs. We then validated the optimized conditions targeting 78 "dispensable" genes. This work led to the definition of a protocol, featuring the use of double stranded synthetic donor DNAs, which guarantees mutagenesis efficiencies consistently higher than 10% and a robustness of 100%. The procedure can be applied also for simultaneous gene deletions.

Conclusions: This work defines for the first time the robustness of a CRISPR/Cas9-based protocol based on a large sample size. Since the technical solutions here proposed can be applied to other similar procedures, the data could be of general interest for the scientific community working on bacterial genome editing and, in particular, for those involved in synthetic biology projects requiring high throughput procedures.

Keywords: CRISPR-Cas9; High-throughput genome editing; Synthetic biology.

Publication types

  • Validation Study

MeSH terms

  • CRISPR-Cas Systems*
  • Escherichia coli / genetics*
  • Gene Deletion
  • Gene Editing*
  • Genome, Bacterial
  • Homologous Recombination
  • Multigene Family*
  • Mutagenesis
  • RNA, Guide
  • Recombinases / metabolism
  • Synthetic Biology / methods


  • RNA, Guide
  • Recombinases